Scientific Reference

Selank + Semax

Evidence profile: Component evidence only — this formulation has not itself been studied

This combination pairs neurotrophic and neurotransmitter-modulating peptides studied for cognitive and stress-response signalling pathways.\n\nSemax influences neurotrophic activity, while Selank modulates neurotransmitter systems. No clinical trials have evaluated the combination.

Published Research

  • [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]

    Medvedev VE et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014 · Clinical · Evidence for Selank

    PMID 25176261 — View on PubMed